HK Stock Market Move | YIDU TECH(02158) surged over 9% in the morning session.

On January 12, after the opening of YIDU TECH (02158), the stock price surged strongly, with an increase of over 9% at one point. As of the time of writing, it was up 7.45% to HK$6.35, with a trading volume of HK$1.49 billion. In terms of news, recently, the "Key Laboratory for the Research and Translational Application of Multi-Modal Intelligent Diagnosis and Treatment System of Beijing Municipality", jointly established by Peking University First Hospital and YIDU TECH, was successfully approved. The laboratory will focus on the intelligent diagnosis and treatment research of cardiorenal metabolic syndrome, marking another key milestone in YIDU TECH's continuous development of specialized intelligent diagnosis and treatment. As the core co-builder of the laboratory, YIDU TECH will inject its large-scale modeling technology capabilities into the research and development chain of the laboratory to provide a solid foundation for the implementation of intelligent diagnosis and treatment. The global AI medical market is entering a trillion-dollar growth channel. According to a report by Grand View Research, the global AI medical market is expected to reach approximately $26.65 billion (approximately RMB 186.1 billion) in 2024, and is expected to soar to approximately $505.59 billion (approximately RMB 3.5 trillion) by 2033, with a compound annual growth rate of 38.8% during this period. Dongguan Securities stated that with domestic technology giants actively deploying in the AI medical field, it is expected to rapidly promote the informatization and popularization of medical care in China, accelerate the implementation of AI-specific application scenarios, and medical care may become an important breakthrough for AI-specific application scenarios.